So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!
Parabilis Medicines said it would sell 33.5 million shares at $20 apiece, for a total of $670 million.
Park Square Executive Search has placed Jonathan Sussman as Chief Product and Technology Officer at SETWorks, a software platform that...
Park Square has placed Aimee Rametta as Chief Marketing Officer at Veracross, a PE-backed (BV Investment Partners) industry-leading...
Park Square has placed John Maraganore as Advisor at Oak HC/FT.
Few leaders in biotechnology have successfully willed an entirely new class of medicine into existence, but Oak’s newest advisor, John...…
Park Square has placed Srikanth Pendyala, M.D. as Chief Medical Officer at Infinimmune.
Infinimmune, a biotechnology company pioneering antibody discovery and design, today announced the appointment of Srikanth Pendyala,...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net